These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6300230)

  • 1. The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues.
    Lopez-Berestein G; Mehta K; Mehta R; Juliano RL; Hersh EM
    J Immunol; 1983 Apr; 130(4):1500-2. PubMed ID: 6300230
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
    Sone S; Mutsuura S; Ogawara M; Tsubura E
    J Immunol; 1984 Apr; 132(4):2105-10. PubMed ID: 6699409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of production of interleukin 1 by human blood monocytes activated to the antitumor state by liposome-encapsulated muramyl tripeptide.
    Tandon P; Utsugi T; Sone S
    Cancer Res; 1986 Oct; 46(10):5039-44. PubMed ID: 3489519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide.
    Kleinerman ES; Erickson KL; Schroit AJ; Fogler WE; Fidler IJ
    Cancer Res; 1983 May; 43(5):2010-4. PubMed ID: 6831430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
    Saiki I; Sone S; Fogler WE; Kleinerman ES; Lopez-Berestein G; Fidler IJ
    Cancer Res; 1985 Dec; 45(12 Pt 1):6188-93. PubMed ID: 3933823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.
    Fogler WE; Fidler IJ
    Int J Immunopharmacol; 1987; 9(2):141-50. PubMed ID: 3583507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
    J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
    Phillips NC; Rioux J; Tsao MS
    Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dried preparation of liposomes containing muramyl tripeptide phosphatidylethanolamine as a potent activator of human blood monocytes to the antitumor state.
    Sone S; Utsugi T; Tandon P; Ogawara M
    Cancer Immunol Immunother; 1986; 22(3):191-6. PubMed ID: 3731204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Induction of tumoricidal properties in human monocytes by synergism between interferon-gamma and liposome-entrapped muramyl tripeptide].
    Utsugi T; Sone S; Tandon P; Ogawara M; Shimizu E; Nii A; Nakanishi M; Shono M; Ogura T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3161-8. PubMed ID: 3096216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of novel derivatives of muramyl dipeptide on the immune system].
    Kaliuzhin OV; Fuks BB; Bovin NV; Zemliakov AE; Chirva VIa
    Biull Eksp Biol Med; 1994 May; 117(5):510-3. PubMed ID: 9296705
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes.
    Sone S; Fidler IJ
    Cell Immunol; 1981 Jan; 57(1):42-50. PubMed ID: 7214534
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
    Reisser D; Jeannin JF; Martin F
    C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide].
    Umanskiĭ VIu; Stefanov AV; Los' GV; Andronova TM; Balitskiĭ KP
    Dokl Akad Nauk SSSR; 1986; 286(2):474-6. PubMed ID: 3004870
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of muramyl dipeptide on superoxide anion release and on anti-microbial activity of human macrophages.
    Wilson CB; Bohnsack J; Weaver WM
    Clin Exp Immunol; 1982 Aug; 49(2):371-6. PubMed ID: 6290115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation of tumoricidal properties in human blood monocytes by muramyl dipeptide requires specific intracellular interaction.
    Fogler WE; Fidler IJ
    J Immunol; 1986 Mar; 136(6):2311-7. PubMed ID: 2936824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo effect of doxorubicin combined with liposome-encapsulated muramyl tripeptide on canine monocyte activation.
    Shi F; MacEwen EG; Kurzman ID
    Cancer Res; 1993 Sep; 53(17):3986-91. PubMed ID: 8358727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ImmTher, a lipophilic disaccharide derivative of muramyl dipeptide, up-regulates specific monocyte cytokine genes and activates monocyte-mediated tumoricidal activity.
    Worth LL; Jia SF; An T; Kleinerman ES
    Cancer Immunol Immunother; 1999 Sep; 48(6):312-20. PubMed ID: 10473806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in situ induction of tumoricidal activity in alveolar macrophages by liposomes containing muramyl dipeptide is a thymus-independent process.
    Fidler IJ
    J Immunol; 1981 Oct; 127(4):1719-20. PubMed ID: 6974201
    [No Abstract]   [Full Text] [Related]  

  • 20. Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response.
    Pabst MJ; Hedegaard HB; Johnston RB
    J Immunol; 1982 Jan; 128(1):123-8. PubMed ID: 6274954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.